Abstract
Purpose
The purpose of the study was to compare serum level of Arginase II in patients with vasculogenic erectile dysfunction (ED) versus healthy controls and to assess if its level is affected by severity of ED.
Methods
This is a prospective study that compared Arginase II in 40 patients with ED versus 40 healthy controls. Patients were excluded if they had any pelvic trauma or pelvic surgery, hormonal disorders, Peyronie’s disease, smoking, drug addiction or systemic illnesses. ED was evaluated by the validated Arabic version of the abbreviated five-item form of the international index of erectile function (IIEF-5). Serum arginase II level was assayed using ELIZA. Mann–Whitney, Kruskal–Wallis and Chi-square tests and Spearman correlation were used as appropriate and confirmed by logistic regression model.
Results
22 (55%) patients had DM. 15 (37.5%), 7 (17%), 6 (15%) and 12 (30%) patients suffered from severe, moderate, mild to moderate and mild ED, respectively. The level of serum Arginase II was significantly higher in patients than controls (p < 0.001) and confirmed by multivariate logistic regression analysis. It also correlated significantly with age (r2 = 0.22; p < 0.001) and IIEF-5 score (r2 = 0.8; p < 0.001). Serum Arginase II increased significantly with more severe ED (p < 0.001). Arginase II was also significantly higher in diabetic patients (p < 0.001).
Conclusion
Serum level of Arginase II is significantly higher in patients with vasculogenic ED compared to healthy controls. It correlates significantly with age and IIEF-5 and was significantly affected by the severity of ED.
Similar content being viewed by others
References
NIH Consensus Development Panel on Impotence (1993) Impotence. JAMA 270:83–90
Cassidy A, Franz M, Rim EB (2016) Dietary flavonoid intake and incidence of erectile dysfunction. Am J Clin Nutr 103(2):534–541. https://doi.org/10.3945/ajcn.115.122010
Dean RC, Lue TF (2005) Physiology of penile erection and pathophysiology of erectile dysfunction. Urol Clin N Am 32(4):379–395
Kaiser DR, Billups K, Mason C, Wetterling R, Lundberg JL, Bank AJ (2004) Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. J Am Coll Cardiol 43(2):179–184
Lacchini R, Muniz JJ, Nobre YT, Cologna AJ, Martins AC, Tanus-Santos JE (2015) Relationship between arginase 1 and arginase 2 levels and genetic polymorphisms with erectile dysfunction. Nitric Oxide 51:36–42. https://doi.org/10.1016/j.niox.2015.10.003
De A, Singh MF, Singh V, Ram V, Bisht S (2016) Treatment effect of L-norvaline on the sexual performance of male rats with streptozotocin induced diabetes. Eur J Pharmacol 771:247–254. https://doi.org/10.1016/j.ejphar.2015.12.008
Di Costanzo L, Pique ME, Christianson DW (2007) Crystal structure of human arginase I complexed with thiosemicarbazide reveals an unusual thiocarbonyl mu-sulfide ligand in the binuclear manganese cluster. J Am Chem Soc 129(20):6388–6389
Musicki B, Burnett AL (2006) eNOS function and dysfunction in the penis. Exp Biol Med 231(2):154–165 (Review)
Durante W, Johnson FK, Johnson RA (2007) Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharmacol Physiol 34(9):906–911 (Review)
Pernow J, Jung C (2013) Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal? Cardiovasc Res 98(3):334–343. https://doi.org/10.1093/cvr/cvt036
Bivalacqua TJ, Hellstrom WJ, Kadowitz PJ, Champion HC (2001) Increased expression of arginase II in human diabetic corpus cavernosum: in diabetic-associated erectile dysfunction. Biochem Biophys Res Commun 283(4):923–927
Cox JD, Kim NN, Traish AM, Christianson DW (1999) Arginase-boronic acid complex highlights a physiological role in erectile function. Nat Struct Biol 6(11):1043–1047
Cama E, Colleluori DM, Emig FA et al (2003) Human arginase II: crystal structure and physiological role in male and female sexual arousal. Biochemistry 42(28):8445–8451
Prieto CP, Krause BJ, Quezada C, San Martin R, Sobrevia L, Casanello P (2011) Hypoxia-reduced nitric oxide synthase activity is partially explained by higher arginase-2 activity and cellular redistributionin human umbilical vein endothelium. Placenta 32(12):932–940. https://doi.org/10.1016/j.placenta.2011.09.003
Berkowitz DE, White R, Li D et al (2003) Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation 108(16):2000–2006
Shamloul R, Ghanem H, Abou-zeid A (2004) Validity of the Arabic version of the sexual health inventory for men among Egyptians. Int J Impot Res 16(5):452–455
Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM (1999) Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 11(6):319–326
Ogino K, Murakami I, Wang DH et al (2013) Evaluation of serum arginase I as an oxidative stress biomarkerin a healthy Japanese population using a newly established ELISA. Clin Biochem 46(16–17):1717–1722. https://doi.org/10.1016/j.clinbiochem.2013.08.012
Xie D, Kontos CD, Donatucci CF, Annex BH (2005) Cholesterol feeding reduces vascular endothelial growth factor signaling in rabbit corporal tissues. J Sex Med 2(5):634–640
Hink U, Li H, Mollnau H et al (2001) Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 88(2):E14–E22
Grein U, Schubert GE (2002) Arteriosclerosis of penile arteries: histological findings and their significance in the treatment of erectile dysfunction. Urol Int 68(4):261–264
Barassi A, Corsi Romanelli MM, Pezzilli R et al (2017) Levels of l-arginine and l-citrulline in patients with erectile dysfunction of different etiology. Andrology 5(2):256–261. https://doi.org/10.1111/andr.12293
Mirea O, Donoiu I, Pleşea IE (2012) Arterial aging: a brief review. Rom J Morphol Embryol 53(3):473–477 (Review)
Ryoo S, Gupta G, Benjo A et al (2008) Endothelial arginase II: a novel target for the treatment of atherosclerosis. Circ Res 102(8):923–932. https://doi.org/10.1161/CIRCRESAHA.107.169573
Gorenne I, Kavurma M, Scott S, Bennett M (2006) Vascular smooth muscle cell senescence in atherosclerosis. Cardiovasc Res 72(1):9–17
Sun C, Sun L, Ma H et al (2012) The phenotype and functional alterations of macrophages in mice with hyperglycemia for longterm. J Cell Physiol 227(4):1670–1679. https://doi.org/10.1002/jcp.22891
Morita M, Hayashi T, Ochiai M et al (2014) Oral supplementation with a combination of L-citrulline and L-arginine rapidly increases plasma L-arginine concentration and enhances NO bioavailability. Biochem Biophys Res Commun 454(1):53–57. https://doi.org/10.1016/j.bbrc.2014.10.029
Shiota A, Hotta Y, Kataoka T, Morita M, Maeda Y, Kimura K (2013) Oral L-citrulline supplementation improves erectile function in rats with acute arteriogenicerectile dysfunction. J Sex Med 10(10):2423–2429. https://doi.org/10.1111/jsm.12260
Cormio L, De Siati M, Lorusso F et al (2011) Oral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunction. Urology 77(1):119–122. https://doi.org/10.1016/j.urology.2010.08.028
Lacchini R, Muniz JJ, Nobre YT, Cologna AJ, Martins AC, Tanus-Santos JE (2017) Influence of arginase polymorphisms and arginase levels/activity on the response to erectile dysfunction therapy with sildenafil. Pharmacogenom J. https://doi.org/10.1038/tpj.2017.2 (Epub ahead of print)
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the local ethical committee.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Abdel Wahed, A.S.A.H., Amer, M.A., Abou Mohamed, N.M. et al. Serum Arginase II level can be a novel indicator for erectile dysfunction in patients with vasculogenic erectile dysfunction: a comparative study. Int Urol Nephrol 50, 1389–1395 (2018). https://doi.org/10.1007/s11255-018-1921-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-018-1921-y